GEN - Genetic Engineering and Biotechnology News

The Throughput Paradox: Why Next-Generation Sequencing Bottlenecks Persist Beyond the Sequencer

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
GEN

Multi-Platform Sequencing Study of Four Generations Sheds Light on Mutation Rates

Using sequencing instruments from multiple vendors, scientists from the University of Utah Health, the University of Washington, PacBio, and elsewhere have developed what they claim is the most ...
Nasdaq

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
BioProcess International

Validating Your NGS Assays? Here’s Our Take

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...
Labroots

The Basics of Next Generation Sequencing and its Application in Precision Oncology

The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
Healio

‘Reassuring’ data show most with NSCLC receive guideline-concordant biomarker testing

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
Healthcare Asia Magazine on MSN

Next-generation sequencing services market to reach $8.77b by 2030

The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...
ascopubs.org

Utilization and timing of first tumor next-generation sequencing testing (NGS) in patients (pts) with five most common cancers in the USA.

Treatment preferences between survival and quality of life and their association with clinical outcomes in older adults with advanced cancer. Rates of first NGS relative to the time of death (in pts ...